Soongswang J, McCrindle B W, Jones T K, Vincent R N, Hsu D T, Kuhn M A, Moskowitz W B, Cheatham J P, Kholwadwala D H, Benson L N, Nykanen D G
Division of Cardiology, The Hospital for Sick Children, University of Toronto, Ontario, Canada.
Cardiol Young. 2001 Jan;11(1):54-61. doi: 10.1017/s1047951100012427.
Obstruction of the reconstructed aortic arch, or the neoaortic arch, is now known to be an important factor increasing mortality after the Norwood operation for hypoplastic left heart syndrome. Transcatheter balloon angioplasty has been shown to provide effective relief of both native aortic coarctation and obstructions of the aortic arch occurring subsequent to therapeutic intervention. We sought to determine the outcomes of balloon angioplasty used as an initial treatment for obstruction of the neoaortic arch occurring after the Norwood operation. We gathered the characteristics of 58 patients with such obstruction from 8 institutions, noting procedural factors and outcomes of initial balloon dilation. Obstruction occurred at a median interval of 4 months, with a range from 1.5 months to 6.3 years, after a Norwood operation. Ventricular dysfunction was present before dilation in 13 patients. Mean peak to peak systolic pressure gradients were acutely reduced from 31+/-20 mm Hg to 6+/-9 mmHg (p<0.001), with outcome subjectively judged to be successful in 89%. Three patients with pre-existing ventricular dysfunction died within 48 hours of dilation. There were 10 additional deaths during the period of follow-up, with Kaplan Meier estimates of survival after intervention of 87% at 1 month, 77% at 12 months, and 72% after 15 months. In addition, 9 patients required re-intervention during the period of follow-up, with Kaplan Meier estimates of freedom from re-intervention after dilation of 87% at 6 months, 78% at 12 months and 74% after 18 months. Although transcatheter dilation of neoaortic arch obstructions after Norwood operation is successful, there is a high risk of re-intervention and ongoing mortality in this subgroup of patients. Close follow-up is recommended.
现已明确,重建主动脉弓或新主动脉弓梗阻是增加左心发育不全综合征诺伍德手术后死亡率的一个重要因素。经导管球囊血管成形术已被证明能有效缓解原发性主动脉缩窄以及治疗性干预后发生的主动脉弓梗阻。我们试图确定球囊血管成形术作为诺伍德手术后新主动脉弓梗阻初始治疗方法的疗效。我们收集了来自8家机构的58例此类梗阻患者的特征,记录了初始球囊扩张的操作因素和结果。梗阻发生在诺伍德手术后的中位间隔时间为4个月,范围从1.5个月至6.3年。13例患者在扩张前存在心室功能障碍。平均峰-峰收缩压梯度从31±20 mmHg急剧降至6±9 mmHg(p<0.001),主观判断89%的患者治疗成功。3例术前存在心室功能障碍的患者在扩张后48小时内死亡。随访期间又有10例患者死亡,采用Kaplan-Meier法估计干预后1个月生存率为87%,12个月时为77%,15个月时为72%。此外,9例患者在随访期间需要再次干预,采用Kaplan-Meier法估计扩张后6个月无再次干预的概率为87%,12个月时为78%,18个月时为74%。尽管诺伍德手术后经导管扩张新主动脉弓梗阻是成功的,但该亚组患者再次干预风险高且持续存在死亡风险。建议密切随访。